Wallach, JV. Structure activity relationship (SAR) studies of arylcycloalkylamines as N-methyl-D-aspartate receptor antagonists. Ph. D. Thesis, 19 Dec 2014. #8
Morris, H; Wallach, J. From PCP to MXE: A comprehensive review of the non-medical use of dissociative drugs. Drug Test. Anal., 1 Jul 2014, 6 (7-8), 614-632. 942 kB. https://doi.org/10.1002/dta.1620 #PCA
adder. PCP analogs (cumulative). Bluelight, 20 May 2010. 792 kB. From bluelight.org PCP analogs (Cumulative)
Kalir, A; Teomy, S; Amir, A; Fuchs, P; Lee, SA; Holsztynska, EJ; Rocki, W; Domino, EF. N-Allyl analogs of phencyclidine: chemical synthesis and pharmacological properties. J. Med. Chem., 1 Oct 1984, 27 (10), 1267–1271. 681 kB. https://doi.org/10.1021/jm00376a006 #1 NMR
Shulgin, AT; MacLean, DE. Illicit synthesis of phencyclidine (PCP) and several of its analogs. Clin. Toxicol., 1 Jan 1976, 9 (4), 553–560. 352 kB. https://doi.org/10.3109/15563657608988157 #7, Cyclohexalamine Rhodium.
Maddox, VH; Godefroi, EF; Parcell, RF. The synthesis of phencyclidine and other 1-arylcyclohexylamines. J. Med. Chem., 1 Mar 1965, 8 (2), 230–235. 696 kB. https://doi.org/10.1021/jm00326a019 #59 UV,other
Kalir, A. Structure activity relationships of phencyclidine derivatives. In PCP (phencyclidine), historical and current perspectives; Domino, EF, Ed., NPP Books, Ann Arbor, MI, 1 Jan 1981; pp 31–46. 2.3 MB.
Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.
Bertron, JL; Seto, M; Lindsley, CW. DARK classics in chemical neuroscience: Phencyclidine (PCP). ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2459-2474. 9.9 MB. https://doi.org/10.1021/acschemneuro.8b00266 #4
Bailey, K; Legault, D. Identification of cyclohexamine, phencyclidine and simple analogues by carbon-13 nuclear magnetic resonance spectroscopy. Anal. Chim. Acta, 15 Jan 1980, 113 (2), 375–381. 571 kB. https://doi.org/10.1016/S0003-2670(01)93755-9 #I NMR